Role of IL-6 in Progress of Estrogen Promoting Lung Adenocarcinoma in Mice and Its Mechanism

Objective To explore the role of IL-6 in the progress of Estrogen(E2) promoting lung adenocarcinoma in mice and its possible mechanism. Methods Urethane-induced lung adenocarcinoma models of female Kunming mice were established, and divided as follows(n=9 in each group): the control, E2, E2+estrogen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Zhongliu fangzhi yanjiu 2016-01, Vol.43 (4)
Hauptverfasser: Ren, Nili, Chen, Ping
Format: Artikel
Sprache:chi
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page
container_title Zhongliu fangzhi yanjiu
container_volume 43
creator Ren, Nili
Chen, Ping
description Objective To explore the role of IL-6 in the progress of Estrogen(E2) promoting lung adenocarcinoma in mice and its possible mechanism. Methods Urethane-induced lung adenocarcinoma models of female Kunming mice were established, and divided as follows(n=9 in each group): the control, E2, E2+estrogen inhibitors(E2I), E2I, IL-6 and E2+IL-6 group. 16 weeks later, we sacrificed mice and tested weight changes, tumorigenicity, the total number of nodules, tumor grade, and lung indices. At the same time, we detected the content of E2/IL-6 in serum specimens by enzyme-linked immunoassay (ELISA), ER[beta]/IL-6 mRNA levels by RT-PCR, and the protein expression of ER[beta], Akt, MAPK, p-ER beta, p-Akt, p-MAPK by Western blot. Results The pulmonary nodules rate in Kunming mice were 87.04% (47/54); the lung adenocarcinoma rate were 70.37%(38/54); the total number of nodules, tumor grade, and lung indices in E2 group were significantly higher than those in E2+E2I and E2I group (P
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808675072</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1808675072</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_18086750723</originalsourceid><addsrcrecordid>eNqVi80KgkAUhWdRkJTvMMs2wjXzZxthJChEtAxkGq82MM6Ud3z_NHqBNufjfJyzYF4IAEEWp9mK-UTqARCGsI9S8Nj9ajVy2_KiDBKuDL8MthuQaHY5uanhV_bWKdPxcpzi0KCxUgxSGduL-VUpiVyYhheOeIXyKYyifsOWrdCE_o9rtj3lt-M5eA32PSK5ulckUWth0I5UhxlkSRpDuov-mH4Av15GFQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1808675072</pqid></control><display><type>article</type><title>Role of IL-6 in Progress of Estrogen Promoting Lung Adenocarcinoma in Mice and Its Mechanism</title><source>DOAJ Directory of Open Access Journals</source><creator>Ren, Nili ; Chen, Ping</creator><creatorcontrib>Ren, Nili ; Chen, Ping</creatorcontrib><description>Objective To explore the role of IL-6 in the progress of Estrogen(E2) promoting lung adenocarcinoma in mice and its possible mechanism. Methods Urethane-induced lung adenocarcinoma models of female Kunming mice were established, and divided as follows(n=9 in each group): the control, E2, E2+estrogen inhibitors(E2I), E2I, IL-6 and E2+IL-6 group. 16 weeks later, we sacrificed mice and tested weight changes, tumorigenicity, the total number of nodules, tumor grade, and lung indices. At the same time, we detected the content of E2/IL-6 in serum specimens by enzyme-linked immunoassay (ELISA), ER[beta]/IL-6 mRNA levels by RT-PCR, and the protein expression of ER[beta], Akt, MAPK, p-ER beta, p-Akt, p-MAPK by Western blot. Results The pulmonary nodules rate in Kunming mice were 87.04% (47/54); the lung adenocarcinoma rate were 70.37%(38/54); the total number of nodules, tumor grade, and lung indices in E2 group were significantly higher than those in E2+E2I and E2I group (P&lt;0.05); and above detection index in E2 grou</description><identifier>ISSN: 1000-8578</identifier><language>chi</language><ispartof>Zhongliu fangzhi yanjiu, 2016-01, Vol.43 (4)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Ren, Nili</creatorcontrib><creatorcontrib>Chen, Ping</creatorcontrib><title>Role of IL-6 in Progress of Estrogen Promoting Lung Adenocarcinoma in Mice and Its Mechanism</title><title>Zhongliu fangzhi yanjiu</title><description>Objective To explore the role of IL-6 in the progress of Estrogen(E2) promoting lung adenocarcinoma in mice and its possible mechanism. Methods Urethane-induced lung adenocarcinoma models of female Kunming mice were established, and divided as follows(n=9 in each group): the control, E2, E2+estrogen inhibitors(E2I), E2I, IL-6 and E2+IL-6 group. 16 weeks later, we sacrificed mice and tested weight changes, tumorigenicity, the total number of nodules, tumor grade, and lung indices. At the same time, we detected the content of E2/IL-6 in serum specimens by enzyme-linked immunoassay (ELISA), ER[beta]/IL-6 mRNA levels by RT-PCR, and the protein expression of ER[beta], Akt, MAPK, p-ER beta, p-Akt, p-MAPK by Western blot. Results The pulmonary nodules rate in Kunming mice were 87.04% (47/54); the lung adenocarcinoma rate were 70.37%(38/54); the total number of nodules, tumor grade, and lung indices in E2 group were significantly higher than those in E2+E2I and E2I group (P&lt;0.05); and above detection index in E2 grou</description><issn>1000-8578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqVi80KgkAUhWdRkJTvMMs2wjXzZxthJChEtAxkGq82MM6Ud3z_NHqBNufjfJyzYF4IAEEWp9mK-UTqARCGsI9S8Nj9ajVy2_KiDBKuDL8MthuQaHY5uanhV_bWKdPxcpzi0KCxUgxSGduL-VUpiVyYhheOeIXyKYyifsOWrdCE_o9rtj3lt-M5eA32PSK5ulckUWth0I5UhxlkSRpDuov-mH4Av15GFQ</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Ren, Nili</creator><creator>Chen, Ping</creator><scope>7TO</scope><scope>H94</scope></search><sort><creationdate>20160101</creationdate><title>Role of IL-6 in Progress of Estrogen Promoting Lung Adenocarcinoma in Mice and Its Mechanism</title><author>Ren, Nili ; Chen, Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_18086750723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ren, Nili</creatorcontrib><creatorcontrib>Chen, Ping</creatorcontrib><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Zhongliu fangzhi yanjiu</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ren, Nili</au><au>Chen, Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of IL-6 in Progress of Estrogen Promoting Lung Adenocarcinoma in Mice and Its Mechanism</atitle><jtitle>Zhongliu fangzhi yanjiu</jtitle><date>2016-01-01</date><risdate>2016</risdate><volume>43</volume><issue>4</issue><issn>1000-8578</issn><abstract>Objective To explore the role of IL-6 in the progress of Estrogen(E2) promoting lung adenocarcinoma in mice and its possible mechanism. Methods Urethane-induced lung adenocarcinoma models of female Kunming mice were established, and divided as follows(n=9 in each group): the control, E2, E2+estrogen inhibitors(E2I), E2I, IL-6 and E2+IL-6 group. 16 weeks later, we sacrificed mice and tested weight changes, tumorigenicity, the total number of nodules, tumor grade, and lung indices. At the same time, we detected the content of E2/IL-6 in serum specimens by enzyme-linked immunoassay (ELISA), ER[beta]/IL-6 mRNA levels by RT-PCR, and the protein expression of ER[beta], Akt, MAPK, p-ER beta, p-Akt, p-MAPK by Western blot. Results The pulmonary nodules rate in Kunming mice were 87.04% (47/54); the lung adenocarcinoma rate were 70.37%(38/54); the total number of nodules, tumor grade, and lung indices in E2 group were significantly higher than those in E2+E2I and E2I group (P&lt;0.05); and above detection index in E2 grou</abstract></addata></record>
fulltext fulltext
identifier ISSN: 1000-8578
ispartof Zhongliu fangzhi yanjiu, 2016-01, Vol.43 (4)
issn 1000-8578
language chi
recordid cdi_proquest_miscellaneous_1808675072
source DOAJ Directory of Open Access Journals
title Role of IL-6 in Progress of Estrogen Promoting Lung Adenocarcinoma in Mice and Its Mechanism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A27%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20IL-6%20in%20Progress%20of%20Estrogen%20Promoting%20Lung%20Adenocarcinoma%20in%20Mice%20and%20Its%20Mechanism&rft.jtitle=Zhongliu%20fangzhi%20yanjiu&rft.au=Ren,%20Nili&rft.date=2016-01-01&rft.volume=43&rft.issue=4&rft.issn=1000-8578&rft_id=info:doi/&rft_dat=%3Cproquest%3E1808675072%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1808675072&rft_id=info:pmid/&rfr_iscdi=true